Concepedia

Publication | Closed Access

Efficacy of rituximab in refractory RRMS

DOI

36

Citations

13

References

2018

Year

Pierre Durozard, Adil Maarouf, Clémence Boutière, Aurélie Ruet, Bruno Brochet, Sandra Vukusic, Clarisse Carra‐Dallière, Pierre Labauge, Guillaume Mathey, Marc Debouverie,
Multiple Sclerosis Journal

Abstract

This study provides level IV evidence that rituximab reduces clinical and MRI disease activity in patients with active RRMS despite immunosuppressive DMT.

References

YearCitations

Page 1